GSK plc
GSK • Drug Manufacturers - General
$50.65
▲ +1.19 (+2.41%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$101.85B
Growth
8.6%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 17.5%Positive revenue growth · 20.3%Positive free cash flow · 5.75Consistent free cash flow · 5/5Reasonable earnings multiple · 6.45
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 29, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$50.65
Change2.41%
Shares Out2.04B
Market Cap$101.85B
52W Range35.45 - 61.70
Beta0.29
P/E11.78
P/S10.72
P/B3.48
P/FCF117.22
EV/Sales13.70
EV/EBITDA37.68
Price$50.65
Change2.41%
Shares Out2.04B
Market Cap$101.85B
52W Range35.45 - 61.70
Beta0.29
P/E11.78
P/S10.72
P/B3.48
P/FCF117.22
EV/Sales13.70
EV/EBITDA37.68
EV/FCF149.76
Earnings Yield8.49%
FCF Yield0.85%
Dividend Yield0.79%
Gross Margin72.40%
Oper. Margin25.52%
Profit Margin17.50%
Debt/Eq1.08
Current Ratio0.82
Quick Ratio0.54
Revenue 5Y8.56%
Target$60.00
Target Upside18.46%
Target Median$60.00
Target Range60.00 - 60.00
Volume3.01M
Avg Volume3.96M
EPS Surprise0.08
Investment DNA
How strong this company looks for long-term investors
84
out of 100
Business Quality
Margins, moat, returns
76/100
Financial Strength
Debt, cash, stability
50/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
93/100
Why this score▼
Stable or improving margins · 17.5%Positive revenue growth · 20.3%Positive free cash flow · 5.75Consistent free cash flow · 5/5Reasonable earnings multiple · 6.45Weak liquidity · 0.82
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 29 analyst votes · 2026-10-20
59/100
Neutral
Bullish
9
Hold
16
Bearish
4
Price Target
2026-07-02
Low
$35.25
Mean
$52.45
Median
$53.00
High
$85.00
🧾
No insider activity
No recent insider transactions available.